GO:0032991 | protein-containing complex | 41.33% (31/75) | 1.74 | 0.0 | 1e-06 |
GO:0140513 | nuclear protein-containing complex | 22.67% (17/75) | 2.57 | 0.0 | 2e-06 |
GO:0044089 | positive regulation of cellular component biogenesis | 10.67% (8/75) | 3.84 | 0.0 | 5.6e-05 |
GO:1902494 | catalytic complex | 21.33% (16/75) | 2.13 | 1e-06 | 0.000229 |
GO:0031595 | nuclear proteasome complex | 4.0% (3/75) | 7.29 | 1e-06 | 0.000239 |
GO:1905368 | peptidase complex | 6.67% (5/75) | 4.92 | 1e-06 | 0.000249 |
GO:0035770 | ribonucleoprotein granule | 10.67% (8/75) | 3.36 | 1e-06 | 0.000254 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 10.67% (8/75) | 3.39 | 1e-06 | 0.000259 |
GO:0005515 | protein binding | 65.33% (49/75) | 0.79 | 1e-06 | 0.00026 |
GO:0051091 | positive regulation of DNA-binding transcription factor activity | 6.67% (5/75) | 4.5 | 3e-06 | 0.000438 |
GO:0017025 | TBP-class protein binding | 5.33% (4/75) | 5.35 | 3e-06 | 0.000471 |
GO:0051246 | regulation of protein metabolic process | 21.33% (16/75) | 1.94 | 3e-06 | 0.000506 |
GO:0043922 | negative regulation by host of viral transcription | 4.0% (3/75) | 6.52 | 5e-06 | 0.000536 |
GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway | 5.33% (4/75) | 5.17 | 5e-06 | 0.000544 |
GO:0048522 | positive regulation of cellular process | 34.67% (26/75) | 1.33 | 4e-06 | 0.00055 |
GO:0045840 | positive regulation of mitotic nuclear division | 5.33% (4/75) | 5.22 | 4e-06 | 0.000582 |
GO:1901992 | positive regulation of mitotic cell cycle phase transition | 6.67% (5/75) | 4.28 | 6e-06 | 0.000654 |
GO:0080090 | regulation of primary metabolic process | 36.0% (27/75) | 1.21 | 1.1e-05 | 0.000779 |
GO:0051171 | regulation of nitrogen compound metabolic process | 34.67% (26/75) | 1.25 | 1.1e-05 | 0.000783 |
GO:0003676 | nucleic acid binding | 34.67% (26/75) | 1.25 | 1.1e-05 | 0.000808 |
GO:0010468 | regulation of gene expression | 32.0% (24/75) | 1.32 | 1.2e-05 | 0.000819 |
GO:0090575 | RNA polymerase II transcription regulator complex | 6.67% (5/75) | 4.12 | 1.1e-05 | 0.000836 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 5.33% (4/75) | 4.9 | 1e-05 | 0.000841 |
GO:0071985 | multivesicular body sorting pathway | 5.33% (4/75) | 4.9 | 1e-05 | 0.000841 |
GO:0003727 | single-stranded RNA binding | 8.0% (6/75) | 3.63 | 1e-05 | 0.000853 |
GO:0010638 | positive regulation of organelle organization | 9.33% (7/75) | 3.26 | 9e-06 | 0.000862 |
GO:0010604 | positive regulation of macromolecule metabolic process | 25.33% (19/75) | 1.6 | 1e-05 | 0.000893 |
GO:0000932 | P-body | 6.67% (5/75) | 4.0 | 1.6e-05 | 0.000898 |
GO:0044087 | regulation of cellular component biogenesis | 12.0% (9/75) | 2.62 | 1.6e-05 | 0.000914 |
GO:0090068 | positive regulation of cell cycle process | 8.0% (6/75) | 3.52 | 1.4e-05 | 0.000918 |
GO:1901989 | positive regulation of cell cycle phase transition | 6.67% (5/75) | 4.02 | 1.5e-05 | 0.000933 |
GO:0060255 | regulation of macromolecule metabolic process | 36.0% (27/75) | 1.19 | 1.6e-05 | 0.000938 |
GO:0043228 | non-membrane-bounded organelle | 25.33% (19/75) | 1.52 | 2e-05 | 0.000949 |
GO:0043232 | intracellular non-membrane-bounded organelle | 25.33% (19/75) | 1.52 | 2e-05 | 0.000949 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 10.67% (8/75) | 2.79 | 2.1e-05 | 0.00095 |
GO:0045931 | positive regulation of mitotic cell cycle | 6.67% (5/75) | 3.95 | 1.9e-05 | 0.00095 |
GO:0140296 | general transcription initiation factor binding | 5.33% (4/75) | 4.7 | 1.8e-05 | 0.000953 |
GO:1990429 | peroxisomal importomer complex | 2.67% (2/75) | 8.03 | 2.2e-05 | 0.000966 |
GO:0051785 | positive regulation of nuclear division | 5.33% (4/75) | 4.69 | 1.9e-05 | 0.000972 |
GO:0034515 | proteasome storage granule | 4.0% (3/75) | 5.86 | 1.9e-05 | 0.000975 |
GO:0043328 | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 4.0% (3/75) | 5.75 | 2.4e-05 | 0.001037 |
GO:0010556 | regulation of macromolecule biosynthetic process | 28.0% (21/75) | 1.39 | 2.5e-05 | 0.001066 |
GO:0043966 | histone H3 acetylation | 5.33% (4/75) | 4.57 | 2.6e-05 | 0.001066 |
GO:0048518 | positive regulation of biological process | 37.33% (28/75) | 1.11 | 2.7e-05 | 0.00111 |
GO:0045324 | late endosome to vacuole transport | 5.33% (4/75) | 4.5 | 3.1e-05 | 0.001214 |
GO:0031531 | thyrotropin-releasing hormone receptor binding | 2.67% (2/75) | 7.7 | 3.6e-05 | 0.001261 |
GO:0099576 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission | 2.67% (2/75) | 7.7 | 3.6e-05 | 0.001261 |
GO:0016560 | protein import into peroxisome matrix, docking | 2.67% (2/75) | 7.7 | 3.6e-05 | 0.001261 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2.67% (2/75) | 7.7 | 3.6e-05 | 0.001261 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 2.67% (2/75) | 7.7 | 3.6e-05 | 0.001261 |
GO:0008285 | negative regulation of cell population proliferation | 8.0% (6/75) | 3.28 | 3.8e-05 | 0.001271 |
GO:0070717 | poly-purine tract binding | 5.33% (4/75) | 4.43 | 3.8e-05 | 0.001293 |
GO:0005488 | binding | 73.33% (55/75) | 0.55 | 3.3e-05 | 0.001293 |
GO:0005667 | transcription regulator complex | 8.0% (6/75) | 3.24 | 4.3e-05 | 0.001405 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 22.67% (17/75) | 1.54 | 5.1e-05 | 0.001633 |
GO:0006338 | chromatin remodeling | 8.0% (6/75) | 3.18 | 5.4e-05 | 0.001705 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 18.67% (14/75) | 1.75 | 5.6e-05 | 0.001738 |
GO:0070603 | SWI/SNF superfamily-type complex | 5.33% (4/75) | 4.24 | 6.2e-05 | 0.001895 |
GO:0009893 | positive regulation of metabolic process | 25.33% (19/75) | 1.39 | 6.8e-05 | 0.00204 |
GO:0050794 | regulation of cellular process | 50.67% (38/75) | 0.8 | 7.4e-05 | 0.002122 |
GO:0033565 | ESCRT-0 complex | 2.67% (2/75) | 7.22 | 7.6e-05 | 0.002138 |
GO:0032806 | carboxy-terminal domain protein kinase complex | 4.0% (3/75) | 5.22 | 7.4e-05 | 0.00215 |
GO:0019222 | regulation of metabolic process | 38.67% (29/75) | 1.01 | 7.3e-05 | 0.002155 |
GO:0140297 | DNA-binding transcription factor binding | 8.0% (6/75) | 3.08 | 7.9e-05 | 0.002195 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 6.67% (5/75) | 3.5 | 8.5e-05 | 0.002256 |
GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 4.0% (3/75) | 5.15 | 8.5e-05 | 0.002286 |
GO:0051130 | positive regulation of cellular component organization | 10.67% (8/75) | 2.5 | 8.5e-05 | 0.002311 |
GO:0070651 | nonfunctional rRNA decay | 2.67% (2/75) | 7.03 | 0.000101 | 0.002424 |
GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 2.67% (2/75) | 7.03 | 0.000101 | 0.002424 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 2.67% (2/75) | 7.03 | 0.000101 | 0.002424 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 4.0% (3/75) | 5.09 | 9.7e-05 | 0.002429 |
GO:1901970 | positive regulation of mitotic sister chromatid separation | 4.0% (3/75) | 5.09 | 9.7e-05 | 0.002429 |
GO:2000144 | positive regulation of DNA-templated transcription initiation | 4.0% (3/75) | 5.09 | 9.7e-05 | 0.002429 |
GO:0045787 | positive regulation of cell cycle | 8.0% (6/75) | 3.04 | 9.4e-05 | 0.002462 |
GO:0043130 | ubiquitin binding | 5.33% (4/75) | 3.98 | 0.000125 | 0.002933 |
GO:0000502 | proteasome complex | 4.0% (3/75) | 4.97 | 0.000125 | 0.002953 |
GO:0060260 | regulation of transcription initiation by RNA polymerase II | 4.0% (3/75) | 4.94 | 0.000132 | 0.003052 |
GO:1904949 | ATPase complex | 5.33% (4/75) | 3.95 | 0.000137 | 0.003076 |
GO:0050789 | regulation of biological process | 54.67% (41/75) | 0.7 | 0.000136 | 0.003091 |
GO:0051254 | positive regulation of RNA metabolic process | 17.33% (13/75) | 1.72 | 0.00014 | 0.003106 |
GO:1905369 | endopeptidase complex | 4.0% (3/75) | 4.83 | 0.000166 | 0.003463 |
GO:0034063 | stress granule assembly | 4.0% (3/75) | 4.83 | 0.000166 | 0.003463 |
GO:0048523 | negative regulation of cellular process | 26.67% (20/75) | 1.25 | 0.000163 | 0.003497 |
GO:0090261 | positive regulation of inclusion body assembly | 2.67% (2/75) | 6.7 | 0.000162 | 0.003507 |
GO:0007088 | regulation of mitotic nuclear division | 5.33% (4/75) | 3.89 | 0.000162 | 0.003546 |
GO:0043170 | macromolecule metabolic process | 41.33% (31/75) | 0.89 | 0.000181 | 0.003702 |
GO:0044093 | positive regulation of molecular function | 10.67% (8/75) | 2.34 | 0.00018 | 0.003722 |
GO:0019904 | protein domain specific binding | 9.33% (7/75) | 2.56 | 0.000191 | 0.003851 |
GO:0045893 | positive regulation of DNA-templated transcription | 16.0% (12/75) | 1.76 | 0.000194 | 0.003867 |
GO:0005675 | transcription factor TFIIH holo complex | 2.67% (2/75) | 6.57 | 0.000198 | 0.003901 |
GO:1902680 | positive regulation of RNA biosynthetic process | 16.0% (12/75) | 1.75 | 0.000213 | 0.00394 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 16.0% (12/75) | 1.75 | 0.000211 | 0.003942 |
GO:0031328 | positive regulation of cellular biosynthetic process | 18.67% (14/75) | 1.58 | 0.000204 | 0.003947 |
GO:0032182 | ubiquitin-like protein binding | 5.33% (4/75) | 3.79 | 0.00021 | 0.003973 |
GO:0060090 | molecular adaptor activity | 6.67% (5/75) | 3.22 | 0.000209 | 0.003985 |
GO:2000142 | regulation of DNA-templated transcription initiation | 4.0% (3/75) | 4.73 | 0.000204 | 0.003987 |
GO:0031326 | regulation of cellular biosynthetic process | 28.0% (21/75) | 1.18 | 0.000222 | 0.004033 |
GO:0031323 | regulation of cellular metabolic process | 33.33% (25/75) | 1.03 | 0.000227 | 0.004039 |
GO:0006325 | chromatin organization | 8.0% (6/75) | 2.81 | 0.000221 | 0.00405 |
GO:1990234 | transferase complex | 12.0% (9/75) | 2.11 | 0.000227 | 0.004077 |
GO:0033276 | transcription factor TFTC complex | 2.67% (2/75) | 6.44 | 0.000237 | 0.004125 |
GO:0046695 | SLIK (SAGA-like) complex | 2.67% (2/75) | 6.44 | 0.000237 | 0.004125 |
GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 4.0% (3/75) | 4.63 | 0.000248 | 0.004197 |
GO:1905820 | positive regulation of chromosome separation | 4.0% (3/75) | 4.63 | 0.000248 | 0.004197 |
GO:0009891 | positive regulation of biosynthetic process | 18.67% (14/75) | 1.55 | 0.000245 | 0.004219 |
GO:0003682 | chromatin binding | 9.33% (7/75) | 2.48 | 0.000266 | 0.004461 |
GO:1990904 | ribonucleoprotein complex | 12.0% (9/75) | 2.07 | 0.000283 | 0.004617 |
GO:0010494 | cytoplasmic stress granule | 5.33% (4/75) | 3.68 | 0.000281 | 0.004628 |
GO:0099170 | postsynaptic modulation of chemical synaptic transmission | 2.67% (2/75) | 6.33 | 0.000279 | 0.004642 |
GO:0003712 | transcription coregulator activity | 8.0% (6/75) | 2.74 | 0.000289 | 0.004672 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 17.33% (13/75) | 1.6 | 0.000302 | 0.004832 |
GO:0140030 | modification-dependent protein binding | 5.33% (4/75) | 3.64 | 0.000308 | 0.004894 |
GO:0008104 | protein localization | 14.67% (11/75) | 1.78 | 0.000328 | 0.005031 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 2.67% (2/75) | 6.22 | 0.000326 | 0.005032 |
GO:0140035 | ubiquitination-like modification-dependent protein binding | 2.67% (2/75) | 6.22 | 0.000326 | 0.005032 |
GO:0140036 | ubiquitin-dependent protein binding | 2.67% (2/75) | 6.22 | 0.000326 | 0.005032 |
GO:0009889 | regulation of biosynthetic process | 28.0% (21/75) | 1.13 | 0.000347 | 0.005266 |
GO:0006357 | regulation of transcription by RNA polymerase II | 13.33% (10/75) | 1.89 | 0.000354 | 0.00528 |
GO:0051851 | modulation by host of symbiont process | 4.0% (3/75) | 4.46 | 0.000353 | 0.005317 |
GO:0031325 | positive regulation of cellular metabolic process | 21.33% (16/75) | 1.37 | 0.000361 | 0.005346 |
GO:0007346 | regulation of mitotic cell cycle | 8.0% (6/75) | 2.64 | 0.00041 | 0.005977 |
GO:0033043 | regulation of organelle organization | 10.67% (8/75) | 2.17 | 0.000409 | 0.006004 |
GO:0046426 | negative regulation of receptor signaling pathway via JAK-STAT | 2.67% (2/75) | 6.03 | 0.000428 | 0.006139 |
GO:1904893 | negative regulation of receptor signaling pathway via STAT | 2.67% (2/75) | 6.03 | 0.000428 | 0.006139 |
GO:0003677 | DNA binding | 21.33% (16/75) | 1.34 | 0.000449 | 0.006329 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 4.0% (3/75) | 4.34 | 0.000448 | 0.006371 |
GO:0050657 | nucleic acid transport | 5.33% (4/75) | 3.48 | 0.000473 | 0.006566 |
GO:0050658 | RNA transport | 5.33% (4/75) | 3.48 | 0.000473 | 0.006566 |
GO:0051236 | establishment of RNA localization | 5.33% (4/75) | 3.47 | 0.000483 | 0.006647 |
GO:0065007 | biological regulation | 56.0% (42/75) | 0.61 | 0.00051 | 0.00687 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6.67% (5/75) | 2.94 | 0.000507 | 0.006877 |
GO:1901363 | heterocyclic compound binding | 42.67% (32/75) | 0.79 | 0.000505 | 0.006902 |
GO:0036402 | proteasome-activating activity | 2.67% (2/75) | 5.86 | 0.000545 | 0.007279 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 4.0% (3/75) | 4.24 | 0.000558 | 0.007403 |
GO:0071824 | protein-DNA complex subunit organization | 5.33% (4/75) | 3.41 | 0.000564 | 0.007427 |
GO:0097159 | organic cyclic compound binding | 42.67% (32/75) | 0.78 | 0.000575 | 0.007508 |
GO:0051427 | hormone receptor binding | 2.67% (2/75) | 5.78 | 0.000608 | 0.007611 |
GO:0051428 | peptide hormone receptor binding | 2.67% (2/75) | 5.78 | 0.000608 | 0.007611 |
GO:0016580 | Sin3 complex | 2.67% (2/75) | 5.78 | 0.000608 | 0.007611 |
GO:0016525 | negative regulation of angiogenesis | 2.67% (2/75) | 5.78 | 0.000608 | 0.007611 |
GO:1901343 | negative regulation of vasculature development | 2.67% (2/75) | 5.78 | 0.000608 | 0.007611 |
GO:2000181 | negative regulation of blood vessel morphogenesis | 2.67% (2/75) | 5.78 | 0.000608 | 0.007611 |
GO:0003713 | transcription coactivator activity | 5.33% (4/75) | 3.37 | 0.00062 | 0.007705 |
GO:0016570 | histone modification | 8.0% (6/75) | 2.52 | 0.000632 | 0.007745 |
GO:0051783 | regulation of nuclear division | 5.33% (4/75) | 3.37 | 0.000632 | 0.007795 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 4.0% (3/75) | 4.17 | 0.000641 | 0.007796 |
GO:1903541 | regulation of exosomal secretion | 2.67% (2/75) | 5.7 | 0.000675 | 0.008103 |
GO:1903543 | positive regulation of exosomal secretion | 2.67% (2/75) | 5.7 | 0.000675 | 0.008103 |
GO:0016573 | histone acetylation | 5.33% (4/75) | 3.34 | 0.00068 | 0.008106 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 4.0% (3/75) | 4.13 | 0.000684 | 0.008107 |
GO:1902531 | regulation of intracellular signal transduction | 10.67% (8/75) | 2.04 | 0.000735 | 0.008262 |
GO:0018394 | peptidyl-lysine acetylation | 5.33% (4/75) | 3.31 | 0.00073 | 0.008265 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 4.0% (3/75) | 4.1 | 0.00073 | 0.008316 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 4.0% (3/75) | 4.12 | 0.000707 | 0.00832 |
GO:0008134 | transcription factor binding | 8.0% (6/75) | 2.49 | 0.000721 | 0.008322 |
GO:0070682 | proteasome regulatory particle assembly | 2.67% (2/75) | 5.63 | 0.000745 | 0.008326 |
GO:0006475 | internal protein amino acid acetylation | 5.33% (4/75) | 3.32 | 0.000717 | 0.008332 |
GO:0018393 | internal peptidyl-lysine acetylation | 5.33% (4/75) | 3.32 | 0.000717 | 0.008332 |
GO:0140535 | intracellular protein-containing complex | 10.67% (8/75) | 2.04 | 0.00073 | 0.008368 |
GO:0045899 | positive regulation of RNA polymerase II transcription preinitiation complex assembly | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:0017056 | structural constituent of nuclear pore | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:1902692 | regulation of neuroblast proliferation | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:0000124 | SAGA complex | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:0051123 | RNA polymerase II preinitiation complex assembly | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:0000338 | protein deneddylation | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 2.67% (2/75) | 5.57 | 0.000819 | 0.008506 |
GO:0010965 | regulation of mitotic sister chromatid separation | 4.0% (3/75) | 4.04 | 0.000827 | 0.008547 |
GO:0009292 | horizontal gene transfer | 4.0% (3/75) | 4.07 | 0.000778 | 0.008584 |
GO:0009294 | DNA-mediated transformation | 4.0% (3/75) | 4.07 | 0.000778 | 0.008584 |
GO:0099080 | supramolecular complex | 10.67% (8/75) | 2.02 | 0.000788 | 0.008639 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 13.33% (10/75) | 1.74 | 0.000798 | 0.008704 |
GO:0070727 | cellular macromolecule localization | 14.67% (11/75) | 1.63 | 0.000804 | 0.008709 |
GO:0007281 | germ cell development | 5.33% (4/75) | 3.24 | 0.000868 | 0.008917 |
GO:0006355 | regulation of DNA-templated transcription | 21.33% (16/75) | 1.25 | 0.000898 | 0.009064 |
GO:0031597 | cytosolic proteasome complex | 2.67% (2/75) | 5.5 | 0.000895 | 0.009092 |
GO:0051252 | regulation of RNA metabolic process | 22.67% (17/75) | 1.19 | 0.000892 | 0.009111 |
GO:1903506 | regulation of nucleic acid-templated transcription | 21.33% (16/75) | 1.24 | 0.000925 | 0.009291 |
GO:2001141 | regulation of RNA biosynthetic process | 21.33% (16/75) | 1.24 | 0.000931 | 0.009295 |
GO:0006473 | protein acetylation | 5.33% (4/75) | 3.21 | 0.000944 | 0.009367 |
GO:0045898 | regulation of RNA polymerase II transcription preinitiation complex assembly | 2.67% (2/75) | 5.44 | 0.000976 | 0.009473 |
GO:0110156 | methylguanosine-cap decapping | 2.67% (2/75) | 5.44 | 0.000976 | 0.009473 |
GO:0006622 | protein targeting to lysosome | 2.67% (2/75) | 5.44 | 0.000976 | 0.009473 |
GO:0043433 | negative regulation of DNA-binding transcription factor activity | 4.0% (3/75) | 3.97 | 0.00096 | 0.009476 |
GO:0010608 | post-transcriptional regulation of gene expression | 9.33% (7/75) | 2.14 | 0.001055 | 0.010192 |
GO:0110154 | RNA decapping | 2.67% (2/75) | 5.33 | 0.001146 | 0.010831 |
GO:0070897 | transcription preinitiation complex assembly | 2.67% (2/75) | 5.33 | 0.001146 | 0.010831 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 2.67% (2/75) | 5.33 | 0.001146 | 0.010831 |
GO:0046907 | intracellular transport | 12.0% (9/75) | 1.79 | 0.001133 | 0.010885 |
GO:0000123 | histone acetyltransferase complex | 4.0% (3/75) | 3.87 | 0.001167 | 0.010971 |
GO:0031334 | positive regulation of protein-containing complex assembly | 4.0% (3/75) | 3.84 | 0.001231 | 0.011392 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 4.0% (3/75) | 3.84 | 0.001231 | 0.011392 |
GO:0051128 | regulation of cellular component organization | 16.0% (12/75) | 1.46 | 0.001223 | 0.011436 |
GO:0032784 | regulation of DNA-templated transcription elongation | 4.0% (3/75) | 3.82 | 0.001297 | 0.011941 |
GO:0031327 | negative regulation of cellular biosynthetic process | 13.33% (10/75) | 1.64 | 0.001304 | 0.011942 |
GO:0006417 | regulation of translation | 8.0% (6/75) | 2.32 | 0.001313 | 0.011961 |
GO:0008540 | proteasome regulatory particle, base subcomplex | 2.67% (2/75) | 5.22 | 0.001329 | 0.011992 |
GO:0016075 | rRNA catabolic process | 2.67% (2/75) | 5.22 | 0.001329 | 0.011992 |
GO:0033045 | regulation of sister chromatid segregation | 4.0% (3/75) | 3.78 | 0.0014 | 0.012566 |
GO:0051641 | cellular localization | 16.0% (12/75) | 1.44 | 0.001425 | 0.012722 |
GO:0031324 | negative regulation of cellular metabolic process | 16.0% (12/75) | 1.43 | 0.001533 | 0.013351 |
GO:0008180 | COP9 signalosome | 2.67% (2/75) | 5.12 | 0.001526 | 0.013359 |
GO:1901987 | regulation of cell cycle phase transition | 6.67% (5/75) | 2.58 | 0.00152 | 0.01337 |
GO:0048519 | negative regulation of biological process | 29.33% (22/75) | 0.93 | 0.001544 | 0.013388 |
GO:0015031 | protein transport | 10.67% (8/75) | 1.87 | 0.001515 | 0.013396 |
GO:1905818 | regulation of chromosome separation | 4.0% (3/75) | 3.74 | 0.001508 | 0.013403 |
GO:0016070 | RNA metabolic process | 16.0% (12/75) | 1.42 | 0.001555 | 0.013415 |
GO:0009890 | negative regulation of biosynthetic process | 13.33% (10/75) | 1.61 | 0.001568 | 0.013462 |
GO:0016197 | endosomal transport | 5.33% (4/75) | 3.01 | 0.001583 | 0.013525 |
GO:0065009 | regulation of molecular function | 14.67% (11/75) | 1.5 | 0.001628 | 0.013708 |
GO:0031248 | protein acetyltransferase complex | 4.0% (3/75) | 3.7 | 0.001622 | 0.013724 |
GO:1902493 | acetyltransferase complex | 4.0% (3/75) | 3.7 | 0.001622 | 0.013724 |
GO:0070822 | Sin3-type complex | 2.67% (2/75) | 5.03 | 0.001736 | 0.014481 |
GO:0045765 | regulation of angiogenesis | 2.67% (2/75) | 5.03 | 0.001736 | 0.014481 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 16.0% (12/75) | 1.4 | 0.001751 | 0.014537 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 5.33% (4/75) | 2.96 | 0.001793 | 0.014819 |
GO:0044389 | ubiquitin-like protein ligase binding | 6.67% (5/75) | 2.52 | 0.001849 | 0.015075 |
GO:0034248 | regulation of cellular amide metabolic process | 8.0% (6/75) | 2.22 | 0.001835 | 0.015094 |
GO:1901342 | regulation of vasculature development | 2.67% (2/75) | 4.98 | 0.001845 | 0.015113 |
GO:0008160 | protein tyrosine phosphatase activator activity | 1.33% (1/75) | 9.03 | 0.001919 | 0.015428 |
GO:0004151 | dihydroorotase activity | 1.33% (1/75) | 9.03 | 0.001919 | 0.015428 |
GO:0061908 | phagophore | 1.33% (1/75) | 9.03 | 0.001919 | 0.015428 |
GO:0033036 | macromolecule localization | 14.67% (11/75) | 1.47 | 0.001928 | 0.015434 |
GO:0061462 | protein localization to lysosome | 2.67% (2/75) | 4.94 | 0.001958 | 0.015606 |
GO:0043543 | protein acylation | 5.33% (4/75) | 2.92 | 0.001969 | 0.01562 |
GO:0065004 | protein-DNA complex assembly | 4.0% (3/75) | 3.59 | 0.002038 | 0.016096 |
GO:0070461 | SAGA-type complex | 2.67% (2/75) | 4.9 | 0.002075 | 0.01624 |
GO:0036452 | ESCRT complex | 2.67% (2/75) | 4.9 | 0.002075 | 0.01624 |
GO:0042127 | regulation of cell population proliferation | 9.33% (7/75) | 1.96 | 0.002147 | 0.016736 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 22.67% (17/75) | 1.07 | 0.002229 | 0.017297 |
GO:0045184 | establishment of protein localization | 10.67% (8/75) | 1.78 | 0.002244 | 0.017337 |
GO:0051983 | regulation of chromosome segregation | 4.0% (3/75) | 3.52 | 0.002317 | 0.017669 |
GO:1902554 | serine/threonine protein kinase complex | 4.0% (3/75) | 3.52 | 0.002317 | 0.017669 |
GO:0003674 | molecular_function | 76.0% (57/75) | 0.35 | 0.002311 | 0.017781 |
GO:0034605 | cellular response to heat | 5.33% (4/75) | 2.85 | 0.002356 | 0.017894 |
GO:0000785 | chromatin | 6.67% (5/75) | 2.42 | 0.00246 | 0.0186 |
GO:0044238 | primary metabolic process | 48.0% (36/75) | 0.59 | 0.002573 | 0.019047 |
GO:0090083 | regulation of inclusion body assembly | 2.67% (2/75) | 4.74 | 0.002571 | 0.019114 |
GO:0005669 | transcription factor TFIID complex | 2.67% (2/75) | 4.74 | 0.002571 | 0.019114 |
GO:0016251 | RNA polymerase II general transcription initiation factor activity | 2.67% (2/75) | 4.74 | 0.002571 | 0.019114 |
GO:0007034 | vacuolar transport | 5.33% (4/75) | 2.82 | 0.002568 | 0.019339 |
GO:0033044 | regulation of chromosome organization | 5.33% (4/75) | 2.81 | 0.002631 | 0.019401 |
GO:0043248 | proteasome assembly | 2.67% (2/75) | 4.7 | 0.002703 | 0.019764 |
GO:0036257 | multivesicular body organization | 2.67% (2/75) | 4.7 | 0.002703 | 0.019764 |
GO:0008150 | biological_process | 77.33% (58/75) | 0.33 | 0.002715 | 0.01977 |
GO:1903047 | mitotic cell cycle process | 8.0% (6/75) | 2.1 | 0.002792 | 0.020084 |
GO:0010605 | negative regulation of macromolecule metabolic process | 17.33% (13/75) | 1.25 | 0.002789 | 0.020146 |
GO:0051668 | localization within membrane | 6.67% (5/75) | 2.38 | 0.002779 | 0.020154 |
GO:0034661 | ncRNA catabolic process | 2.67% (2/75) | 4.67 | 0.002838 | 0.020171 |
GO:1904892 | regulation of receptor signaling pathway via STAT | 2.67% (2/75) | 4.67 | 0.002838 | 0.020171 |
GO:1990351 | transporter complex | 4.0% (3/75) | 3.42 | 0.002832 | 0.02029 |
GO:0006139 | nucleobase-containing compound metabolic process | 21.33% (16/75) | 1.08 | 0.002964 | 0.020981 |
GO:0030718 | germ-line stem cell population maintenance | 2.67% (2/75) | 4.63 | 0.002976 | 0.020986 |
GO:0051028 | mRNA transport | 4.0% (3/75) | 3.39 | 0.002999 | 0.021062 |
GO:0090304 | nucleic acid metabolic process | 18.67% (14/75) | 1.18 | 0.003028 | 0.021182 |
GO:0010564 | regulation of cell cycle process | 8.0% (6/75) | 2.07 | 0.003126 | 0.021534 |
GO:0016234 | inclusion body | 2.67% (2/75) | 4.6 | 0.003117 | 0.021554 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 2.67% (2/75) | 4.6 | 0.003117 | 0.021554 |
GO:0034046 | poly(G) binding | 2.67% (2/75) | 4.6 | 0.003117 | 0.021554 |
GO:0003723 | RNA binding | 16.0% (12/75) | 1.3 | 0.003148 | 0.0216 |
GO:0051649 | establishment of localization in cell | 12.0% (9/75) | 1.57 | 0.003267 | 0.02233 |
GO:0051241 | negative regulation of multicellular organismal process | 9.33% (7/75) | 1.85 | 0.003291 | 0.022409 |
GO:1902911 | protein kinase complex | 4.0% (3/75) | 3.33 | 0.003351 | 0.022727 |
GO:0015931 | nucleobase-containing compound transport | 5.33% (4/75) | 2.7 | 0.003395 | 0.022936 |
GO:0072666 | establishment of protein localization to vacuole | 4.0% (3/75) | 3.31 | 0.003536 | 0.023801 |
GO:1902751 | positive regulation of cell cycle G2/M phase transition | 2.67% (2/75) | 4.5 | 0.00356 | 0.023871 |
GO:0006397 | mRNA processing | 6.67% (5/75) | 2.29 | 0.003619 | 0.024176 |
GO:0003219 | cardiac right ventricle formation | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:1990893 | mitotic chromosome centromere condensation | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0042292 | URM1 activating enzyme activity | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0061604 | molybdopterin-synthase sulfurtransferase activity | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0061605 | molybdopterin-synthase adenylyltransferase activity | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0016587 | Isw1 complex | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0060962 | regulation of ribosomal protein gene transcription by RNA polymerase II | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0060963 | positive regulation of ribosomal protein gene transcription by RNA polymerase II | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0048133 | male germ-line stem cell asymmetric division | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:0016598 | protein arginylation | 1.33% (1/75) | 8.03 | 0.003834 | 0.024506 |
GO:1902117 | positive regulation of organelle assembly | 2.67% (2/75) | 4.44 | 0.00387 | 0.024561 |
GO:0005771 | multivesicular body | 2.67% (2/75) | 4.44 | 0.00387 | 0.024561 |
GO:2000177 | regulation of neural precursor cell proliferation | 2.67% (2/75) | 4.47 | 0.003713 | 0.024714 |
GO:0071705 | nitrogen compound transport | 13.33% (10/75) | 1.43 | 0.003816 | 0.025305 |
GO:0019538 | protein metabolic process | 25.33% (19/75) | 0.91 | 0.004194 | 0.026334 |
GO:0008143 | poly(A) binding | 2.67% (2/75) | 4.38 | 0.004192 | 0.026418 |
GO:0045921 | positive regulation of exocytosis | 2.67% (2/75) | 4.38 | 0.004192 | 0.026418 |
GO:0051247 | positive regulation of protein metabolic process | 9.33% (7/75) | 1.78 | 0.004238 | 0.026515 |
GO:0010498 | proteasomal protein catabolic process | 6.67% (5/75) | 2.24 | 0.004261 | 0.026568 |
GO:0006807 | nitrogen compound metabolic process | 42.67% (32/75) | 0.61 | 0.004332 | 0.026914 |
GO:0005575 | cellular_component | 76.0% (57/75) | 0.32 | 0.004504 | 0.027888 |
GO:0016607 | nuclear speck | 5.33% (4/75) | 2.58 | 0.004568 | 0.028186 |
GO:0072665 | protein localization to vacuole | 4.0% (3/75) | 3.17 | 0.004629 | 0.028461 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5.33% (4/75) | 2.57 | 0.004661 | 0.028561 |
GO:0031981 | nuclear lumen | 4.0% (3/75) | 3.15 | 0.004778 | 0.029177 |
GO:0010324 | membrane invagination | 2.67% (2/75) | 4.27 | 0.004873 | 0.029657 |
GO:0023051 | regulation of signaling | 17.33% (13/75) | 1.16 | 0.004948 | 0.03001 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 2.67% (2/75) | 4.24 | 0.005051 | 0.030322 |
GO:0140223 | general transcription initiation factor activity | 2.67% (2/75) | 4.24 | 0.005051 | 0.030322 |
GO:0006508 | proteolysis | 10.67% (8/75) | 1.59 | 0.005049 | 0.030519 |
GO:0006886 | intracellular protein transport | 8.0% (6/75) | 1.92 | 0.005121 | 0.030637 |
GO:0051726 | regulation of cell cycle | 9.33% (7/75) | 1.73 | 0.005173 | 0.030848 |
GO:0050768 | negative regulation of neurogenesis | 2.67% (2/75) | 4.22 | 0.005231 | 0.030988 |
GO:0090311 | regulation of protein deacetylation | 2.67% (2/75) | 4.22 | 0.005231 | 0.030988 |
GO:0010646 | regulation of cell communication | 17.33% (13/75) | 1.14 | 0.005255 | 0.031023 |
GO:0051961 | negative regulation of nervous system development | 2.67% (2/75) | 4.19 | 0.005415 | 0.031863 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 8.0% (6/75) | 1.9 | 0.005486 | 0.032171 |
GO:0097396 | response to interleukin-17 | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0097398 | cellular response to interleukin-17 | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0030159 | signaling receptor complex adaptor activity | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0003128 | heart field specification | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0003139 | secondary heart field specification | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0003207 | cardiac chamber formation | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0003211 | cardiac ventricle formation | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0051664 | nuclear pore localization | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0097013 | phagocytic vesicle lumen | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0004046 | aminoacylase activity | 1.33% (1/75) | 7.44 | 0.005745 | 0.032411 |
GO:0051253 | negative regulation of RNA metabolic process | 10.67% (8/75) | 1.54 | 0.006117 | 0.034398 |
GO:0051248 | negative regulation of protein metabolic process | 8.0% (6/75) | 1.85 | 0.006411 | 0.035938 |
GO:0051603 | proteolysis involved in protein catabolic process | 8.0% (6/75) | 1.85 | 0.006517 | 0.036415 |
GO:0009892 | negative regulation of metabolic process | 17.33% (13/75) | 1.1 | 0.006605 | 0.036791 |
GO:0030261 | chromosome condensation | 2.67% (2/75) | 4.03 | 0.006781 | 0.037539 |
GO:0017145 | stem cell division | 2.67% (2/75) | 4.03 | 0.006781 | 0.037539 |
GO:0006635 | fatty acid beta-oxidation | 2.67% (2/75) | 4.0 | 0.006988 | 0.038443 |
GO:0008333 | endosome to lysosome transport | 2.67% (2/75) | 4.0 | 0.006988 | 0.038443 |
GO:0140110 | transcription regulator activity | 13.33% (10/75) | 1.3 | 0.00706 | 0.0386 |
GO:0005654 | nucleoplasm | 12.0% (9/75) | 1.39 | 0.007059 | 0.038715 |
GO:0042169 | SH2 domain binding | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0003905 | alkylbase DNA N-glycosylase activity | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0035851 | Krueppel-associated box domain binding | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0042475 | odontogenesis of dentin-containing tooth | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0060788 | ectodermal placode formation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0060789 | hair follicle placode formation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0061198 | fungiform papilla formation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:2001228 | regulation of response to gamma radiation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:2001229 | negative regulation of response to gamma radiation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0002143 | tRNA wobble position uridine thiolation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0008265 | Mo-molybdopterin cofactor sulfurase activity | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0032447 | protein urmylation | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:1903241 | U2-type prespliceosome assembly | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0005962 | mitochondrial isocitrate dehydrogenase complex (NAD+) | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0045242 | isocitrate dehydrogenase complex (NAD+) | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0032777 | Piccolo NuA4 histone acetyltransferase complex | 1.33% (1/75) | 7.03 | 0.007653 | 0.03942 |
GO:0019899 | enzyme binding | 13.33% (10/75) | 1.28 | 0.007691 | 0.0395 |
GO:0072657 | protein localization to membrane | 5.33% (4/75) | 2.36 | 0.007743 | 0.03965 |
GO:0022402 | cell cycle process | 10.67% (8/75) | 1.48 | 0.00788 | 0.04012 |
GO:0009987 | cellular process | 66.67% (50/75) | 0.35 | 0.007909 | 0.040157 |
GO:0005829 | cytosol | 25.33% (19/75) | 0.83 | 0.007864 | 0.040157 |
GO:0030163 | protein catabolic process | 6.67% (5/75) | 2.04 | 0.007413 | 0.040409 |
GO:0022607 | cellular component assembly | 14.67% (11/75) | 1.21 | 0.007465 | 0.040565 |
GO:0010721 | negative regulation of cell development | 2.67% (2/75) | 3.9 | 0.008063 | 0.040706 |
GO:0043405 | regulation of MAP kinase activity | 2.67% (2/75) | 3.9 | 0.008063 | 0.040706 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 4.0% (3/75) | 2.87 | 0.008181 | 0.041182 |
GO:0030371 | translation repressor activity | 2.67% (2/75) | 3.88 | 0.008287 | 0.041598 |
GO:0043065 | positive regulation of apoptotic process | 4.0% (3/75) | 2.84 | 0.008603 | 0.043066 |
GO:0042176 | regulation of protein catabolic process | 5.33% (4/75) | 2.3 | 0.008985 | 0.044852 |
GO:0046601 | positive regulation of centriole replication | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0010092 | specification of animal organ identity | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0034657 | GID complex | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0071390 | cellular response to ecdysone | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0001751 | compound eye photoreceptor cell differentiation | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0001975 | response to amphetamine | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0007492 | endoderm development | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0032732 | positive regulation of interleukin-1 production | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:1902435 | regulation of male mating behavior | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:1902437 | positive regulation of male mating behavior | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0004792 | thiosulfate sulfurtransferase activity | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0032324 | molybdopterin cofactor biosynthetic process | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0042868 | antisense RNA metabolic process | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0004449 | isocitrate dehydrogenase (NAD+) activity | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0098722 | asymmetric stem cell division | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:0098728 | germline stem cell asymmetric division | 1.33% (1/75) | 6.7 | 0.009557 | 0.045169 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 2.67% (2/75) | 3.76 | 0.009685 | 0.045652 |
GO:0017148 | negative regulation of translation | 4.0% (3/75) | 2.78 | 0.009716 | 0.045673 |
GO:0002039 | p53 binding | 2.67% (2/75) | 3.8 | 0.009208 | 0.045835 |
GO:0016604 | nuclear body | 6.67% (5/75) | 1.94 | 0.009856 | 0.046213 |
GO:0001664 | G protein-coupled receptor binding | 2.67% (2/75) | 3.74 | 0.009928 | 0.046427 |
GO:0010629 | negative regulation of gene expression | 8.0% (6/75) | 1.73 | 0.009493 | 0.047122 |
GO:1902533 | positive regulation of intracellular signal transduction | 5.33% (4/75) | 2.25 | 0.010116 | 0.04718 |
GO:1903530 | regulation of secretion by cell | 4.0% (3/75) | 2.75 | 0.010183 | 0.047368 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 10.67% (8/75) | 1.41 | 0.010406 | 0.048283 |
GO:0006401 | RNA catabolic process | 4.0% (3/75) | 2.73 | 0.010663 | 0.049343 |